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INTRODUCTION: The intestinal epithelium is one of the most rapidly dividing tissues in the 
mammalian organism, with near complete replacement of the epithelial monolayer every 7-10 
days (Wright et al., 1984). The start site of this impressive cellular renewal and division begins 
with a pool of intestinal epithelial stem cells (IESCs) that reside at the base of the crypts. The 
crypts are small depressions in the intestine that extend to the lamina propria and house both the 
IESCs and supporting niche cells at its base (Cheng et al., 1974). As the IESCs divide, their 
progeny migrate upward to the top of the crypt towards the lumen, into what is termed the 
transit-amplifying zone. Once in this zone, the transit 
amplifying cells mature into one of four well defined post-
mitotic cell lineages: absorptive enterocytes, goblet cells, 
enteroendocrine cells, and Paneth cells (Figure 1). With the 
exception of the Paneth cells, all of these cell types continue 
to migrate upward into the large finger-like villi, where they 
live for several days before dying and being sloughed off at 
the tip of the villus (Cheng et al., 1974). Each cell type in the 
villus has a distinct role; absorptive enterocytes are 
responsible for absorbing nutrients and transferring them to 
the bloodstream, goblet cells secrete a protective mucus layer 
over the epithelium, and enteroendocrine cells produce 
important signaling hormones (Cheng et al., 1974). Paneth cells are unique in that they migrate 
downward from the transit-amplifying zone back to the crypt base where they secrete 
antimicrobial peptides and serve as niche cells to the stem cells (Sato et al., 2011). This rapid 
 
Figure 1. Diagram depicting 
crypt-villus axis, showing 
direction of cell migration 
from the crypt base to villus 
tip. 
cycle of tissue renewal, coupled with well-defined post-mitotic lineages, make the intestinal 
epithelium an ideal model for the study of factors that regulate the potency and self renewing 
capability of the IESCs, which to date remain poorly understood. Mutations or deficiencies in 
these properties of stem cells, collectively considered “stemness,” lie at the heart of many 
gastrointestinal disorders. Establishing a better understanding of the processes and transcription 
factors that regulate stemness is critical to developing novel cellular and gene-based therapies for 
those afflicted with GI disorders and cancers.  
The Sry-related HMG box (Sox) is a group of highly conserved transcription factors that 
is broadly expressed across tissue systems, particularly during embryogenesis. Interestingly, 
knockout experiments of many Sox factors demonstrate a failure to undergo organogenesis and 
implicate this group of transcription factors as potent regulators of stem cell maintenance and 
differentiation (Gracz et al., 2011). Sox4 causes lethality at embryonic day 10.5 in knockout mice 
due to malformations in the endocardial ridge (Schilham et al., 1996). In addition, Sox4 has been 
shown to play an important role in B-cell, T-cell, and neuronal proliferation and differentiation, 
providing further evidence that Sox4 has crucial regulatory functions in the maintenance and 
differentiation of stem cell populations (Schilham 
et al., 1996, 1997, Bergsland et al, 2006). 
Recently, in situ hybridization has been used to 
show that Sox4 is expressed at the base of 
intestinal crypts, in the known stem cell 
compartment (Figure 2). Given the role of Sox4 
in other tissues and its localization to the stem cell 
zone, these preliminary data collectively suggest 
 
Figure 3. Cartoon gene diagram 
depicting action of Cre recombinase 
carrying out site-specific deletion of 
Sox4. 
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Figure 2. 10X and 40X in situ 
hybridization showing Sox4 mRNA 
localizing to the base of the crypt 
(Magness, unpublished data). 
that Sox4 may be playing a critical role in maintaining and regulating the differentiation of the 
IESCs.  
 In addition to regulating proliferation and differentiation in a variety of tissues, Sox4 has 
long been implicated as playing an oncogenic role in a variety of cancer types. There exists a 
large body of literature showing Sox4 expression is upregulated in cancers of virtually every type 
(for a summary of this research see Table 1, adapted from Vervoort et al., 2013). Despite this 
sizable and growing body of literature, little is known about how Sox4 is contributing to 
tumorigenesis in these cancers.  A landmark paper demonstrated Sox4 to be a master regulator of 
the biological process called Epithelial-Mesenchymal Transition (EMT) in breast tissue. In this 
process, cells begin to lose their epithelial traits such as cell-cell adhesion and polarity, and take 
on more mesenchymal characteristics such as the ability to migrate and invade other tissue types 
(Christofori et al., 2013). This process of EMT mediates epithelial tumor metastasis by 
generating cells capable of invading the basement membrane and entering the circulatory system. 
Recently, cancer cell lines have been used to show a role for Sox4 induced EMT contributing to 
tumor progression in breast, prostate, and liver cancers. These experiments demonstrated that 
overexpression of Sox4 was sufficient to cause cells to undergo EMT and become increasingly 
invasive and migratory in vitro. However, almost no research on the role of Sox4 in tumor 
metastasis via EMT induction has been examined in vivo. And while it has long been known that 
EMT plays an important process in human colorectal cancer metastasis, the mechanistic and 
regulatory details of this potentially Sox4-dependent EMT remains largely unknown (Loboda et 
al., 2011). I hypothesize that Sox4 is the driving force for EMT in colorectal cancer, by 
promoting tumor progression and metastasis.  
 
METHODS:  
The Sox4fl/fl:VilCre Mouse Model: A genome-wide knockout of Sox4 results in embryonic 
lethality. To study the role of Sox4 in the adult intestine, we generated conditional transgenic 
knockout mice using the Cre-lox recombination system (Marioue et al., 2004). In our model, 
Cre-recombinase expression is driven by a villin promoter, a gene that is expressed exclusively 
in the intestinal epithelium. This system allows for an intestinal specific knockout of Sox4 
(Figure 3). To attempt to discern the role of Sox4 in the epithelium, this mouse model will be 
examined using a variety of techniques including RNA and protein analysis. 
 
Table 1. Summary of existing research showing Sox4 upregulation in many cancer types. 
Table adapted from Vervoort et al., 2013. 
The APCmin mouse model:. The APC gene is an component 
of the destruction complex which targets cytoplasmic β-
catenin for degradation. This mouse model contains a 
truncation in one copy of the APC gene Following random 
inactivation of the remaining copy of APC, Wnt signaling is 
constitutively turned on and β-catenin is localized to the 
nucleus where it can act as a transcription factor, promoting 
genes for proliferation and cell growth. In this model, mice 
begin to display multiple intestinal neoplasias as early as 50-
60 days, with more severe and damaging tumor growth 
coming at about 14 weeks (Moser et al. 1990, Su et al. 1992).  
Tissue Processing: Knockout mice with littermate controls for immunohistochemistry and 
quantification were sacrificed at 8-9 weeks after birth. Intestines were dissected out and divided 
into three equal length segments, with segment 1 representing the most proximal section and 
segment 3 the most distal. These sections were then flushed with ice cold Phosphate Buffered 
Saline (PBS) and fixed in 4% Paraformaldehyde (PFA). After fixing for 24 hours at 4°C, tissue 
was transferred to a 30% sucrose solution before it was filleted open to expose the lumen and 
give a flat intestinal segment. The flattened segments were then rolled up in a manner similar to a 
swiss-roll, and frozen in optimal cutting temperature embedding media (OCT). The swiss-rolls 
were then sectioned at a thickness of 6-8 µm, 
Immunohistochemistry and quantification: Staining was performed according to previously 
described protocols (Gracz et al. 2013). Primary antibodies used were raised against murine Ki67, 
lysozyme, Ep-CAM, Mucin-2, Chromogranin-A, and Sox4 and visualized with Cy3 conjugated 
 
Figure 3. Schematic diagram 
showing excision of Sox4 by 
Cre recombinase protein 
specifically in the intestinal 
epithelium. 
secondary antibodies. Nuclear staining was done using bisbenzimide, following primary and 
secondary antibody incubation. For quantification, crypts counted had to meet certain criteria; 
crypts had to be open to the luminal space and extend their base to the lamina propria or muscle 
layer. For goblet cells and enteroendocrine cells, which exist in both the crypt and the villus, 
images for quantification were taken and cell number was quantified separately in the crypt and 
in the villus. Imaging analysis software (ImageJ version 1.48a) was used for cell quantification 
and morphometric analysis.  
Quantitative Real-Time PCR (qRT-PCR): After sacrificing mice at 8-12 weeks of age, 0.5 cm 
segments of jejunal segment number 2 and 
proximal and distal colon were dissected out 
and placed into RNAlater (Qiagen) for 24 
hours at 4° C. RNA was then extracted and 
purified, and cDNA was made using the 
iScript cDNA Synthesis Kit (Bio-Rad). qRT-
PCR was performed with SsoFast Probes 
Supermix with ROX. qRT-PCR data was 
analyzed using StepOne Plus Software.  
Tumor dissociation and flow cytometry 
APCmin mice between 14-16 weeks were 
sacrificed, and the intestines were removed 
and flushed as normal. The intestines were 
then opened longitudinally, and tumors were 
dissected out under a dissecting microscope. 
 
Figure 4. A) Confocal image of SOX4 
protein expression, B) overlayed with nuclei. 
C) Quantification of SO4 high and low 
expressing cell position, n=3 animals, 10 
crypts per animal. 
These tumors were minced with a razor blade to a paste-like consistency and placed in an EDTA 
chelation buffer for 45 minutes at 4° C. These chunks of tissue were then spun down at 1500 rpm 
for 5 minutes and resuspended in pre-warmed Hank’s Balanced Salt Solution (HBSS, Gibco) 
containing dispase and DNase. This suspension was placed at 37° C and shaken lightly every 1.5 
minutes, with samples taken to observe dissociation progress after each step. After 6-10 minutes 
of this enzymatic digestion, the cells were put through a 40 µm filter directly into ice cold PBS 
containing 10% Fetal Bovine Serum (FBS). The single cells were then washed twice with cold 
PBS, and resuspended in IESC media (DMEM, 10% FBS, B27, N2, Pen/Strep, Y27632, NAC). 
Cells in IESC media were stained for 1 hours with EpCAM antibody (EpCAM FITC, Biolegend), 
and washed twice. Live/dead cell exclusion stains were added 10 minutes before flow cytometry. 




Characterizing Sox4 expression patterns 
While in situ hybridization data showed that Sox4 was expressed in the crypts, more specific 
localization of Sox4 expression was needed to associate Sox4 expression with cell position in the 
crypt. To investigate the expression pattern of SOX4 with greater accuracy, a Sox4 antibody was 
used to immunofluorescently label Sox4 expressing cells. In order for this stain to work, a 
protocol first had to be optimized. This was devised to include antigen retrieval, an extended 
primary antibody incubation time, and signal amplification using the biotin-streptavidin system. 
This protocol yielded highly specific binding with little background signal, and revealed a clear 
and distinct expression pattern.  
SOX4 was expressed at both a high and low level in different cells of the crypt (Figure 4). 
The cell position of each subset was quantified and showed that Sox4 low expressing cells were 
primarily at the crypt base, around position +1 to +3 and becoming less frequent towards the top 
of the crypt. The Sox4 high expressing cells, however, were found most frequently at cell 
position +5, a position that is consistent with that of the ‘reserve’ ISC population (Van 
Landeghem et al., 2012).  
Loss of Sox4 results in crypt hyperplasia and hyperproliferation  
Upon first examination of knockout mouse tissue, there was no overt phenotype, with knockout 
mice exhibiting no change in body mass and appearing to have normal crypt-villus architecture. 
However, closer examination revealed that crypts in knockout animals were hyperplastic, 
extending deeper than those in the control animals. To ensure any significant morphological 
changes were discovered, measurements of both crypt depth and width as well as villus height 
and width, were measured using ImageJ software. Morphometric analysis confirmed that crypts 
were on average 150% larger in knockout animals compared to controls. Due to the proliferative 
nature of cells in the crypt, it was hypothesized that hyperproliferation might be the source of the 
hyperplastic crypt morphology.  
 
To test whether or not an increase in cell proliferation was responsible for the oversized crypts, 
slides were stained with the proliferative marker KI67. The percentage of KI67 positive crypt 
cells were quantified and this showed that there was increased proliferation in the crypts of Sox4 
knockout mice compared to controls (Figure 5). While this increase was obvious in many crypts, 
it appeared more subtly in others, but overall was statistically significant (n=3 animals, 25 crypts 
per animal,  p<0.05).  Additionally, it was qualitatively observed that there appeared to be more 
Ki67 positive cells lower in the crypt near the stem cell zone and higher towards the top of the 
crypt, although cell position has yet to be quantified.  
Sox4 regulates Wnt signaling 
 
Figure 5. A, B, C, D) Confocal imagery of EpCAM with quantification of crypt and villus 
dimensions. E, F, G) Confocal images of KI67 staining with quantification, n=3 animals, 25 
crypts per animal. H) qPCR on several direct Wnt target genes, n=3 animals, * indicates 
p<.05 
Due to the significant in KI67 positive proliferating cells, it was hypothesized that Sox4 may be 
involved in regulating Wnt signaling, a well studied pathway that controls cellular growth and 
proliferation14. Quantitative Real-Time PCR on several direct Wnt target genes such as Myc, 
Cyclin D-1, and CD44 confirmed that there was increased Wnt signaling in the knockout animals. 
This result was also observed in tissue from both the proximal and distal colon sections. These 
data suggest that Sox4 is acting as an inhibitor of proliferation, at least partially by down-
regulating Wnt signaling.   
Sox4 regulates secretory lineage allocation in the intestinal epithelium 
 
Figure 6. A-F) Example images of goblet, enteroendocrine, and Paneth cells with 
quantification in crypt and villus. G) Quantification of Paneth cell numbers at each cell 
position. For Goblet cells and enteroendocrine cells n=3 animals, 50 crypts/villi per animal. 
For Paneth cells, n=3 animals, 25 crypts per animal. * indicates p<.05 
Investigating the secretory lineages revealed an interesting pattern, marked by a significant 
decrease in enteroendocrine cells and a concomitant increase in the number of Paneth cells  
(Figure 6). No significant change in the number of goblet cells was observed and goblet cell 
numbers per crypt and per villus was highly variable across biological replicates.  
Sox4 high expressing cells are not label-retaining 
To directly interrogate whether or not Sox4 expressing cells were acting in the label-retaining 
cell described in Buczacki et al. 2013, cells were labeled with the thymidine analog EdU over a 
28 day period using subcutaneously implanted osmotic mini-pumps. Over this 28 day period, 
every cell that enters S phase of the cell cycle is labeled with the thymidine analog which can 
later be visualized with the (Click-it EdU Kit, Invitrogen). The label is then allowed to wash out, 
such that all cells that divide lose their fluorescent label, and those that are long-lived and 
dividing at a slow rate remain labeled. 
 Because the Buczacki paper considers a cell to be label-retaining at 7 to 13 days, we 
examined co-localization of Sox4 and label retaining cells at three wash out timepoints: 0 hours, 
1 week, and 2 weeks. The results showed that Sox4 only co-localized with label-retaining cells at 
a frequency of about 8-9%, and many of these cells may have been mature Paneth cells, which 
are also known to retain labels due to their long-lived nature (Figure 7).  Additionally, all of the 
8-9% of cells which exhibited co-localization were expressing Sox4 at a low level, contrary to 
what was predicted. 
 
Sox4 is highly expressed in small intestinal adenomas and is correlated with decreased EpCAM 
expression 
To begin to investigate the role of Sox4 in tumorigenesis, tissue from APCmin mice was stained 
for Sox4, showing that it is highly expressed in cells of small intestinal adenomas. Interestingly, 
when stained simultaneously with Epithelial Cell Adhesion Molecule (EpCAM), it can be seen 
that cells highly expressing Sox4 appear to have a severely decreased expression of EpCAM 
(Figure 8). These same cells also begin to collapse from a polarized epithelium into an 
unorganized tissue mass and blend with the mesenchyme previously in the deeper tissue layers. 
This process is suggestive of a potential EMT and the invasion that is necessary for tumor 
metastasis.  
 
Figure 7. SOX4 and EdU colocalization at three timpoints, with quantification n=100 SOX4 
expressing cells. 
Flow cytometry can also be used to validate the transition of cells from a high to low 
EpCAM expression profile. Following dissociation of tumors to single cells, a histogram of cells 
expressing EpCAM at different levels confirms that many cells are showing decreased levels of 
EpCAM. This flow cytometric analysis will allow us to derive an appropriate gating strategy for 
using fluorescent activated cell-sorting (FACS) to sort out these cell populations for subsequent 
RNA analysis. 
 
CONCLUSIONS: The expression pattern of Sox4 protein suggests that it may be acting in a 
context-dependent manner, in two different cell types. First, it showed that Sox4 was being 
expressed at a low level in the stem cells, which occupy the base of the crypt at positions +1 +3. 
The identity of cells in which Sox4 is expressed at a high level is a more complicated question. 
Early label-retaining studies propose a quiescent, slowly-dividing stem cell at the +4 position, 
 
Figure 8. A-D) Confocal image of a small intestinal adenoma, expressing SOX4 at a high 
level. E). Flow cytometry overlay graph showing the EpCAM profile of cells dissociated from 
a tumor (red) and from healthy adjacent tissue (green). 
and a recent study using a novel Cyp1a1-H2B-YFP mouse model to more precisely locate the 
label-retaining cell found it predominantly at position +3, but in a variety of positions from +1 to 
+6. It is also well known that the transit amplifying cells occupy positions +6 and up in the crypt. 
Given these facts, it remains possible that Sox4 is acting at a high level in either a long-lived, 
label-retaining, reserve stem cell, or in the rapidly-dividing transit amplifying progenitor cells.  
 The increased levels of KI67 by immunofluorescent quantification and qRT-PCR, 
combined with Sox4 expression in the stem cells, strongly suggest that Sox4 is involved in 
regulating the proliferation of intestinal epithelial stem cells. More specifically, the data suggests 
that in normal tissue, Sox4 is limiting proliferation by down-regulating genes that regulate cell 
cycle entry and growth through the Wnt pathway.  
Quantification of secretory cells in knockout animals reveals a lineage allocation defect 
where cells are preferentially fated towards Paneth cells rather than enteroendocrine cells in the 
absence of SOX4. This result is striking in light of the existence of the label-retaining secretory 
precursor cell that gives rise to both enteroendocrine and Paneth cell lineages described in 
Buczacki et al. 2013. This result lends support to the hypothesis that Sox4 high cells may be 
acting in a label-retaining secretory precursor, pushing this cell towards an enteroendocrine fate 
rather than a Paneth cell fate.  
Given these two functions, a model of Sox4’s context dependent manner can be drawn 
out, where Sox4 is acting at a low level in the stem cells to regulate proliferation, and at a higher 
level in either a progenitor or label retaining cell to regulate secretory cell fate decision (Figure 
9). While the label-retaining cell studies do not support the hypothesis that Sox4 is highly 
expressed in these cells to regulate their fate decision, it does not necessarily rule it out. Since 
only 100 SOX4 positive cells were counted, it remains possible that Sox4 is turned on very 
transiently in the label-retaining secretory precursor and we have simply not caught these cells at 
the right time in their lifespan. However, given the data it seems more likely that Sox4 is 
regulating a short-lived transit amplifying progenitor cell. This joint function of regulating 
proliferation and differentiation is consistent with roles shown in other tissues (Schilham et al., 
1996, 1997, Bergsland et al, 2006).  
 
 In the cancer context, it appears as though Sox4 may have a role unique from its function 
in normal intestinal epithelium homeostasis. The correlation between increased Sox4 levels and 
decreased EpCAM levels suggests that a possible EMT may be occurring in our mouse model of 
colorectal cancer. While it is well established that EMT is an essential program in colorectal 
cancer metastasis, the driver of this program remains unknown. The highly aberrant expression 
 
Figure 9. Diagram with proposed model of Sox4 in normal intestinal epithelium 
of Sox4 in the adenomas combined with previous work in breast tissue implicating Sox4 as a 
master regulator of EMT, provides tanatalizing clues that Sox4 may be responsible for promoting 
the EMT program in colorectal cancer. While further study in this area is certainly needed, 
confirmation of this finding would have profound impact on colorectal cancer research and 
would identify Sox4 as a therapeutic target to manage tumor progression and metastasis.  
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